Human and mouse trigeminal ganglia cell atlas implicates multiple cell types in migraine is a research paper published in Neuron (2022). On theSindex it has a DataRank of 0. It has been cited 198 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Teva Pharmaceutical Industries
Grant: R01NS078263
Teva Pharmaceutical Industries
Grant: R01NS115972
National Institute on Drug Abuse
Grant: DP1DA054343
National Institute of Neurological Disorders and Stroke
Grant: K08NS101064
National Institute of Neurological Disorders and Stroke
Grant: R01NS119476
National Institutes of Health
Grant: 1K08NS101064-01
Control of long gene expression as a novel therapeutic approach for Rett syndrome
National Institutes of Health
Grant: 5DP1DA054343-04
Epigenomic labeling of cells that drive drug abuse behavior
National Institutes of Health
Grant: 5R01NS119476-02
Next Generation Gene Therapy for Refractory Pain
National Institutes of Health
Grant: 2R01NS078263-05A1
MECHANISMS OF CSD-EVOKED PERSISTENT ACTIVATION OF MENINGEAL NOCICEPTORS
National Institutes of Health
Grant: 5R01NS115972-02
Cortical-meningeal interactions underlying migraine headache
Fields of Study
Keywords
Additional file 1 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Additional file 1 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Additional file 4 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Additional file 4 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Additional file 3 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Additional file 2 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Additional file 3 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Additional file 2 of Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy